Baker Brothers Life Sciences Capital (GP), LLC Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Baker Brothers Life Sciences Capital (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Baker Brothers Life Sciences Capital (GP), LLC. Baker Brothers Life Sciences Capital (GP), LLC is 10% Owner in HERON THERAPEUTICS, INC. /DE/ ($HRTX) and 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in INCYTE CORP ($INCY) and 10% Owner in PHARMACYCLICS INC ($PCYC) and 10% Owner in VIROPHARMA INC ($VPHM) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and 10% Owner in ADOLOR CORP ($ADLR) and Director in Ardea Biosciences, Inc./DE ($IBPI) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in AUXILIUM PHARMACEUTICALS INC ($AUXL) and 10% Owner in Ocera Therapeutics, Inc. ($TZYM).
Latest Insider Trading Transactions of Baker Brothers Life Sciences Capital (GP), LLC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADLR, IBPI, AUXL, BCRX, GHDX, HRTX, INCY, TZYM, PCYC, SGEN, GEVA, VPHM
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 14 2012 | TZYM | Ocera Therapeutics ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 3.01 | 34,544 | 103,822 | 3,540,015 | 3.5 M to 3.5 M (+0.99 %) |
| Mar 14 2012 | TZYM | Ocera Therapeutics ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 2.99 | 56,294 | 168,268 | 3,505,471 | 3.4 M to 3.5 M (+1.63 %) |
| Mar 14 2012 | TZYM | Ocera Therapeutics ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 2.96 | 159,015 | 470,382 | 3,449,177 | 3.3 M to 3.4 M (+4.83 %) |
| Mar 14 2012 | TZYM | Ocera Therapeutics ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 2.55 | 572,737 | 1,460,479 | 3,290,162 | 2.7 M to 3.3 M (+21.08 %) |
| Mar 14 2012 | TZYM | Ocera Therapeutics ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 2.34 | 327,769 | 766,848 | 2,717,425 | 2.4 M to 2.7 M (+13.72 %) |
| Mar 14 2012 | TZYM | Ocera Therapeutics ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 1.87 | 44,467 | 83,153 | 2,389,656 | 2.3 M to 2.4 M (+1.90 %) |
| Mar 14 2012 | TZYM | Ocera Therapeutics ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 1.89 | 16,326 | 30,788 | 2,345,189 | 2.3 M to 2.3 M (+0.70 %) |
| Jan 09 2012 | GEVA | SYNAGEVA BIOPHARMA ... | Baker Brothers Life Sciences C ... | Director | Grant | A | 25.18 | 1,077,225 | 27,124,526 | 5,077,676 | 4 M to 5.1 M (+26.93 %) |
| Jan 04 2012 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Option Exercise | X | 6.25 | 355,143 | 2,219,644 | 0 | |
| Jan 04 2012 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | X | 6.25 | 355,143 | 2,219,644 | 15,131,223 | 14.8 M to 15.1 M (+2.40 %) |
| Jan 26 2012 | PCYC | PHARMACYCLICS INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 17.89 | 75,149 | 1,344,626 | 8,574,445 | 8.5 M to 8.6 M (+0.88 %) |
| Jan 26 2012 | PCYC | PHARMACYCLICS INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 17.95 | 168,641 | 3,027,224 | 8,499,296 | 8.3 M to 8.5 M (+2.02 %) |
| Jan 26 2012 | PCYC | PHARMACYCLICS INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 18.43 | 17,571 | 323,877 | 8,330,655 | 8.3 M to 8.3 M (+0.21 %) |
| Jan 26 2012 | PCYC | PHARMACYCLICS INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 18.55 | 107,980 | 2,002,737 | 8,313,084 | 8.2 M to 8.3 M (+1.32 %) |
| Jan 26 2012 | PCYC | PHARMACYCLICS INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 18.01 | 85,169 | 1,533,638 | 8,205,104 | 8.1 M to 8.2 M (+1.05 %) |
| Jan 26 2012 | PCYC | PHARMACYCLICS INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 17.86 | 46,142 | 823,953 | 8,119,935 | 8.1 M to 8.1 M (+0.57 %) |
| Jan 23 2012 | PCYC | PHARMACYCLICS INC | Baker Brothers Life Sciences C ... | 10% Owner | Option Exercise | X | 15.00 | 87 | 1,305 | 0 | |
| Jan 23 2012 | PCYC | PHARMACYCLICS INC | Baker Brothers Life Sciences C ... | 10% Owner | Option Exercise | X | 15.00 | 162 | 2,430 | 87 | |
| Jan 23 2012 | PCYC | PHARMACYCLICS INC | Baker Brothers Life Sciences C ... | 10% Owner | Option Exercise | P | 15.00 | 87 | 1,305 | 249 | |
| Jan 23 2012 | PCYC | PHARMACYCLICS INC | Baker Brothers Life Sciences C ... | 10% Owner | Option Exercise | P | 15.00 | 162 | 2,430 | 162 | |
| Jan 23 2012 | PCYC | PHARMACYCLICS INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 16.84 | 45,574 | 767,462 | 8,073,793 | 8 M to 8.1 M (+0.57 %) |
| Jan 23 2012 | PCYC | PHARMACYCLICS INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 16.88 | 72,997 | 1,232,073 | 8,028,219 | 8 M to 8 M (+0.92 %) |
| Jan 23 2012 | PCYC | PHARMACYCLICS INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 16.90 | 43,644 | 737,474 | 7,955,222 | 7.9 M to 8 M (+0.55 %) |
| Jan 23 2012 | PCYC | PHARMACYCLICS INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | X | 15.00 | 8,700 | 130,500 | 7,911,578 | 7.9 M to 7.9 M (+0.11 %) |
| Jan 23 2012 | PCYC | PHARMACYCLICS INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | X | 15.00 | 16,200 | 243,000 | 7,902,878 | 7.9 M to 7.9 M (+0.21 %) |
| Jan 23 2012 | PCYC | PHARMACYCLICS INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 16.43 | 69,245 | 1,137,958 | 7,886,678 | 7.8 M to 7.9 M (+0.89 %) |
| Jan 23 2012 | PCYC | PHARMACYCLICS INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 16.41 | 178,921 | 2,936,022 | 7,817,433 | 7.6 M to 7.8 M (+2.34 %) |
| Jan 23 2012 | PCYC | PHARMACYCLICS INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 15.81 | 2,449 | 38,716 | 7,638,512 | 7.6 M to 7.6 M (+0.03 %) |
| Jan 23 2012 | PCYC | PHARMACYCLICS INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 16.07 | 10,327 | 165,940 | 7,636,063 | 7.6 M to 7.6 M (+0.14 %) |
| Jan 23 2012 | PCYC | PHARMACYCLICS INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 16.07 | 22,081 | 354,802 | 7,625,736 | 7.6 M to 7.6 M (+0.29 %) |
| Jan 17 2012 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 16.62 | 41,677 | 692,680 | 12,430,783 | 12.4 M to 12.4 M (+0.34 %) |
| Jan 17 2012 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 16.58 | 72,978 | 1,209,822 | 12,389,106 | 12.3 M to 12.4 M (+0.59 %) |
| Jan 17 2012 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 16.46 | 102,856 | 1,692,732 | 12,316,128 | 12.2 M to 12.3 M (+0.84 %) |
| Jan 17 2012 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 16.21 | 219,881 | 3,563,413 | 12,213,272 | 12 M to 12.2 M (+1.83 %) |
| Jan 17 2012 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 16.38 | 105,847 | 1,734,060 | 11,993,391 | 11.9 M to 12 M (+0.89 %) |
| Mar 09 2012 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 30.36 | 19,513 | 592,489 | 8,255,421 | 8.2 M to 8.3 M (+0.24 %) |
| Mar 09 2012 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 29.88 | 22,071 | 659,464 | 8,235,908 | 8.2 M to 8.2 M (+0.27 %) |
| Mar 05 2012 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 30.07 | 69,783 | 2,098,291 | 8,213,837 | 8.1 M to 8.2 M (+0.86 %) |
| Mar 05 2012 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 29.96 | 85,231 | 2,553,188 | 8,144,054 | 8.1 M to 8.1 M (+1.06 %) |
| Mar 05 2012 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 29.52 | 91,459 | 2,699,915 | 8,058,823 | 8 M to 8.1 M (+1.15 %) |
| Mar 05 2012 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 29.47 | 15,288 | 450,543 | 7,967,364 | 8 M to 8 M (+0.19 %) |
| Feb 29 2012 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 29.06 | 156,902 | 4,559,274 | 7,952,076 | 7.8 M to 8 M (+2.01 %) |
| Feb 29 2012 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 29.11 | 51,248 | 1,491,752 | 7,795,174 | 7.7 M to 7.8 M (+0.66 %) |
| Feb 29 2012 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 29.03 | 36,881 | 1,070,678 | 7,743,926 | 7.7 M to 7.7 M (+0.48 %) |
| Feb 23 2012 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 28.12 | 62,098 | 1,746,432 | 7,707,045 | 7.6 M to 7.7 M (+0.81 %) |
| Feb 23 2012 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 27.98 | 5,511 | 154,204 | 7,644,947 | 7.6 M to 7.6 M (+0.07 %) |
| Feb 23 2012 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 27.98 | 46,909 | 1,312,368 | 7,639,436 | 7.6 M to 7.6 M (+0.62 %) |
| Feb 16 2012 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 29.85 | 91,543 | 2,732,998 | 7,592,527 | 7.5 M to 7.6 M (+1.22 %) |
| Feb 16 2012 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 29.61 | 93,088 | 2,756,392 | 7,500,984 | 7.4 M to 7.5 M (+1.26 %) |
| Feb 16 2012 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 28.96 | 349 | 10,108 | 7,407,896 | 7.4 M to 7.4 M (0.00 %) |
| Feb 16 2012 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 28.88 | 32,125 | 927,680 | 7,407,547 | 7.4 M to 7.4 M (+0.44 %) |
| Feb 16 2012 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 28.44 | 55,804 | 1,586,898 | 7,375,422 | 7.3 M to 7.4 M (+0.76 %) |
| Feb 10 2012 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 26.52 | 28,469 | 754,895 | 7,319,618 | 7.3 M to 7.3 M (+0.39 %) |
| Feb 10 2012 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 26.62 | 18,628 | 495,913 | 7,291,149 | 7.3 M to 7.3 M (+0.26 %) |
| Feb 10 2012 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 26.60 | 112,735 | 2,999,123 | 7,272,521 | 7.2 M to 7.3 M (+1.57 %) |
| Feb 10 2012 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 26.24 | 3,883 | 101,874 | 7,159,786 | 7.2 M to 7.2 M (+0.05 %) |
| Feb 10 2012 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 26.33 | 49,670 | 1,307,632 | 7,155,903 | 7.1 M to 7.2 M (+0.70 %) |
| Feb 10 2012 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 26.27 | 2,441 | 64,122 | 7,106,233 | 7.1 M to 7.1 M (+0.03 %) |
| Feb 10 2012 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 26.26 | 60,315 | 1,583,594 | 7,103,792 | 7 M to 7.1 M (+0.86 %) |
| Feb 10 2012 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 26.18 | 135,681 | 3,551,545 | 7,043,477 | 6.9 M to 7 M (+1.96 %) |
| Feb 10 2012 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 26.17 | 6,093 | 159,424 | 6,907,796 | 6.9 M to 6.9 M (+0.09 %) |
| Feb 03 2012 | IBPI | Ardea Biosciences, ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 17.00 | 876,828 | 14,906,076 | 4,922,226 | 4 M to 4.9 M (+21.67 %) |
| Jan 03 2012 | ADLR | ADOLOR CORP | Baker Brothers Life Sciences C ... | 10% Owner | Sell | U | 4.25 | 6,669,338 | 28,344,687 | 0 | 6.7 M to 0 (-100.00 %) |
| Jan 03 2012 | ADLR | ADOLOR CORP | Baker Brothers Life Sciences C ... | 10% Owner | Sell | U | 4.25 | 6,669,338 | 28,344,687 | 0 | 6.7 M to 0 (-100.00 %) |
| Dec 16 2011 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 27.29 | 291,706 | 7,960,161 | 9,840,469 | 9.5 M to 9.8 M (+3.05 %) |
| Oct 06 2011 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 18.18 | 145,763 | 2,650,423 | 9,548,763 | 9.4 M to 9.5 M (+1.55 %) |
| Oct 06 2011 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 17.48 | 45,584 | 796,644 | 9,403,000 | 9.4 M to 9.4 M (+0.49 %) |
| Oct 03 2011 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 17.71 | 445,574 | 7,890,269 | 9,357,416 | 8.9 M to 9.4 M (+5.00 %) |
| Oct 03 2011 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 17.62 | 70,629 | 1,244,589 | 8,911,842 | 8.8 M to 8.9 M (+0.80 %) |
| Oct 03 2011 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 18.08 | 88,657 | 1,602,892 | 8,841,213 | 8.8 M to 8.8 M (+1.01 %) |
| Oct 03 2011 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 18.19 | 43,321 | 788,122 | 8,752,556 | 8.7 M to 8.8 M (+0.50 %) |
| Oct 03 2011 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 18.00 | 159,945 | 2,878,882 | 8,709,235 | 8.5 M to 8.7 M (+1.87 %) |
| Oct 03 2011 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 17.97 | 89,970 | 1,616,392 | 8,549,290 | 8.5 M to 8.5 M (+1.06 %) |
| Nov 04 2011 | GEVA | SYNAGEVA BIOPHARMA ... | Baker Brothers Life Sciences C ... | Director | Grant | A | 0.00 | 3,253,761 | 0 | 4,000,451 | 746.7 K to 4 M (+435.76 %) |
| Nov 04 2011 | GEVA | SYNAGEVA BIOPHARMA ... | Baker Brothers Life Sciences C ... | Director | Grant | A | 0.00 | 251,971 | 0 | 746,690 | 494.7 K to 746.7 K (+50.93 %) |
| Nov 04 2011 | GEVA | SYNAGEVA BIOPHARMA ... | Baker Brothers Life Sciences C ... | Director | Grant | A | 0.00 | 244,194 | 0 | 494,719 | 250.5 K to 494.7 K (+97.47 %) |
| Dec 06 2011 | PCYC | PHARMACYCLICS INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 15.42 | 70,829 | 1,092,403 | 7,603,655 | 7.5 M to 7.6 M (+0.94 %) |
| Dec 06 2011 | PCYC | PHARMACYCLICS INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 15.39 | 17,368 | 267,212 | 7,532,826 | 7.5 M to 7.5 M (+0.23 %) |
| Nov 30 2011 | PCYC | PHARMACYCLICS INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 14.92 | 65,002 | 969,966 | 7,515,458 | 7.5 M to 7.5 M (+0.87 %) |
| Nov 30 2011 | PCYC | PHARMACYCLICS INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 14.26 | 67,210 | 958,300 | 7,450,456 | 7.4 M to 7.5 M (+0.91 %) |
| Nov 30 2011 | PCYC | PHARMACYCLICS INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 14.12 | 95,061 | 1,342,043 | 7,383,246 | 7.3 M to 7.4 M (+1.30 %) |
| Nov 30 2011 | PCYC | PHARMACYCLICS INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 13.38 | 51,574 | 689,978 | 7,288,185 | 7.2 M to 7.3 M (+0.71 %) |
| Nov 30 2011 | PCYC | PHARMACYCLICS INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 13.32 | 98,433 | 1,311,177 | 7,236,611 | 7.1 M to 7.2 M (+1.38 %) |
| Nov 23 2011 | PCYC | PHARMACYCLICS INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 12.76 | 93,194 | 1,189,165 | 7,138,178 | 7 M to 7.1 M (+1.32 %) |
| Nov 23 2011 | PCYC | PHARMACYCLICS INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 12.87 | 60,849 | 782,908 | 7,044,984 | 7 M to 7 M (+0.87 %) |
| Nov 23 2011 | PCYC | PHARMACYCLICS INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 12.51 | 18,282 | 228,662 | 6,984,135 | 7 M to 7 M (+0.26 %) |
| Nov 23 2011 | PCYC | PHARMACYCLICS INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 12.01 | 54,135 | 650,383 | 6,965,853 | 6.9 M to 7 M (+0.78 %) |
| Nov 23 2011 | PCYC | PHARMACYCLICS INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 12.25 | 16,038 | 196,502 | 6,911,718 | 6.9 M to 6.9 M (+0.23 %) |
| Oct 04 2011 | PCYC | PHARMACYCLICS INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 11.62 | 57,805 | 671,463 | 6,895,680 | 6.8 M to 6.9 M (+0.85 %) |
| Oct 04 2011 | PCYC | PHARMACYCLICS INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 11.54 | 24,085 | 277,991 | 6,837,875 | 6.8 M to 6.8 M (+0.35 %) |
| Dec 12 2011 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 13.26 | 178,474 | 2,366,440 | 11,887,544 | 11.7 M to 11.9 M (+1.52 %) |
| Dec 12 2011 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 13.19 | 2,727 | 35,969 | 11,709,070 | 11.7 M to 11.7 M (+0.02 %) |
| Dec 12 2011 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 13.44 | 62,395 | 838,764 | 11,706,343 | 11.6 M to 11.7 M (+0.54 %) |
| Dec 12 2011 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 13.47 | 159,925 | 2,153,422 | 11,643,948 | 11.5 M to 11.6 M (+1.39 %) |
| Dec 07 2011 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 13.22 | 68,955 | 911,895 | 11,484,023 | 11.4 M to 11.5 M (+0.60 %) |
| Dec 07 2011 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 13.21 | 75,948 | 1,003,319 | 11,415,068 | 11.3 M to 11.4 M (+0.67 %) |
| Dec 07 2011 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 13.54 | 146,090 | 1,978,409 | 11,339,120 | 11.2 M to 11.3 M (+1.31 %) |
| Dec 07 2011 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 13.52 | 192,316 | 2,599,651 | 11,193,030 | 11 M to 11.2 M (+1.75 %) |
| Dec 07 2011 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 13.88 | 48,697 | 675,715 | 11,000,714 | 11 M to 11 M (+0.44 %) |
| Dec 07 2011 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 13.89 | 1,023,128 | 14,207,462 | 10,952,017 | 9.9 M to 11 M (+10.30 %) |
| Dec 01 2011 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 13.78 | 267,768 | 3,689,843 | 9,928,889 | 9.7 M to 9.9 M (+2.77 %) |
| Dec 01 2011 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 14.36 | 317,429 | 4,557,709 | 9,661,121 | 9.3 M to 9.7 M (+3.40 %) |
| Dec 01 2011 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 14.18 | 243,425 | 3,450,817 | 9,343,692 | 9.1 M to 9.3 M (+2.67 %) |
| Dec 01 2011 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 13.29 | 257,911 | 3,427,972 | 9,100,267 | 8.8 M to 9.1 M (+2.92 %) |
| Dec 01 2011 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 13.60 | 250,000 | 3,398,925 | 8,842,356 | 8.6 M to 8.8 M (+2.91 %) |
| Dec 01 2011 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 12.23 | 582,677 | 7,127,713 | 8,592,356 | 8 M to 8.6 M (+7.27 %) |
| Dec 01 2011 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 12.19 | 486,969 | 5,935,324 | 8,009,679 | 7.5 M to 8 M (+6.47 %) |
| Dec 05 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 28.39 | 8,390 | 238,192 | 6,901,703 | 6.9 M to 6.9 M (+0.12 %) |
| Dec 05 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 28.50 | 12,066 | 343,880 | 6,893,313 | 6.9 M to 6.9 M (+0.18 %) |
| Dec 05 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 28.06 | 73,430 | 2,060,181 | 6,881,247 | 6.8 M to 6.9 M (+1.08 %) |
| Dec 05 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 28.03 | 23,865 | 669,053 | 6,807,817 | 6.8 M to 6.8 M (+0.35 %) |
| Nov 23 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 25.88 | 47,998 | 1,242,179 | 6,783,952 | 6.7 M to 6.8 M (+0.71 %) |
| Nov 23 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 25.71 | 19,429 | 499,541 | 6,735,954 | 6.7 M to 6.7 M (+0.29 %) |
| Nov 23 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 26.03 | 46,328 | 1,205,927 | 6,716,525 | 6.7 M to 6.7 M (+0.69 %) |
| Nov 23 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 25.91 | 79,984 | 2,071,986 | 6,670,197 | 6.6 M to 6.7 M (+1.21 %) |
| Nov 17 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 27.50 | 9,774 | 268,783 | 6,590,213 | 6.6 M to 6.6 M (+0.15 %) |
| Nov 17 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 27.24 | 14,482 | 394,527 | 6,580,439 | 6.6 M to 6.6 M (+0.22 %) |
| Nov 17 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 27.90 | 23,758 | 662,779 | 6,565,957 | 6.5 M to 6.6 M (+0.36 %) |
| Nov 17 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 27.99 | 16,583 | 464,090 | 6,542,199 | 6.5 M to 6.5 M (+0.25 %) |
| Nov 14 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 27.25 | 39,117 | 1,066,091 | 6,525,616 | 6.5 M to 6.5 M (+0.60 %) |
| Nov 14 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 27.66 | 100,823 | 2,789,006 | 6,486,499 | 6.4 M to 6.5 M (+1.58 %) |
| Nov 14 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 26.89 | 36,956 | 993,654 | 6,385,676 | 6.3 M to 6.4 M (+0.58 %) |
| Nov 14 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 26.66 | 7,725 | 205,975 | 6,348,720 | 6.3 M to 6.3 M (+0.12 %) |
| Nov 14 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 26.80 | 64,754 | 1,735,679 | 6,340,995 | 6.3 M to 6.3 M (+1.03 %) |
| Nov 07 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 26.20 | 60,162 | 1,576,431 | 6,276,241 | 6.2 M to 6.3 M (+0.97 %) |
| Nov 07 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 26.28 | 72,209 | 1,897,602 | 6,216,079 | 6.1 M to 6.2 M (+1.18 %) |
| Nov 07 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 25.78 | 55,920 | 1,441,461 | 6,143,870 | 6.1 M to 6.1 M (+0.92 %) |
| Nov 07 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 24.49 | 20,267 | 496,258 | 6,087,950 | 6.1 M to 6.1 M (+0.33 %) |
| Nov 07 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 24.42 | 954 | 23,296 | 6,067,683 | 6.1 M to 6.1 M (+0.02 %) |
| Sep 26 2011 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 18.13 | 28,000 | 507,632 | 8,459,320 | 8.4 M to 8.5 M (+0.33 %) |
| Sep 26 2011 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 18.13 | 131,641 | 2,386,125 | 8,431,320 | 8.3 M to 8.4 M (+1.59 %) |
| Sep 26 2011 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 17.78 | 54,025 | 960,727 | 8,299,679 | 8.2 M to 8.3 M (+0.66 %) |
| Sep 26 2011 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 17.74 | 157,601 | 2,795,180 | 8,245,654 | 8.1 M to 8.2 M (+1.95 %) |
| Sep 26 2011 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 17.58 | 13,143 | 231,109 | 8,088,053 | 8.1 M to 8.1 M (+0.16 %) |
| Sep 26 2011 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 17.43 | 63,151 | 1,100,469 | 8,074,910 | 8 M to 8.1 M (+0.79 %) |
| Aug 25 2011 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 16.97 | 32,704 | 555,121 | 8,011,759 | 8 M to 8 M (+0.41 %) |
| Aug 12 2011 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 16.12 | 60,578 | 976,366 | 7,979,055 | 7.9 M to 8 M (+0.77 %) |
| Aug 12 2011 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 16.74 | 183,471 | 3,070,662 | 7,918,477 | 7.7 M to 7.9 M (+2.37 %) |
| Jul 05 2011 | GEVA | SYNAGEVA BIOPHARMA ... | Baker Brothers Life Sciences C ... | Director | Buy | J | 0.00 | 9,852 | 0 | 1,252,625 | 1.2 M to 1.3 M (+0.79 %) |
| Sep 08 2011 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 17.27 | 19,729 | 340,700 | 14,776,080 | 14.8 M to 14.8 M (+0.13 %) |
| Sep 08 2011 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 17.06 | 78,326 | 1,336,547 | 14,756,351 | 14.7 M to 14.8 M (+0.53 %) |
| Sep 08 2011 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 17.00 | 31,132 | 529,393 | 14,678,025 | 14.6 M to 14.7 M (+0.21 %) |
| Aug 25 2011 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 15.35 | 8,767 | 134,575 | 14,646,893 | 14.6 M to 14.6 M (+0.06 %) |
| Aug 25 2011 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 15.53 | 469,862 | 7,296,534 | 14,638,126 | 14.2 M to 14.6 M (+3.32 %) |
| Aug 25 2011 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 15.45 | 506,221 | 7,822,734 | 14,168,264 | 13.7 M to 14.2 M (+3.71 %) |
| Aug 25 2011 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 14.98 | 3,371 | 50,485 | 13,662,043 | 13.7 M to 13.7 M (+0.02 %) |
| Aug 25 2011 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 14.98 | 6,205 | 92,947 | 13,658,672 | 13.7 M to 13.7 M (+0.05 %) |
| Aug 25 2011 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 14.79 | 166,638 | 2,464,576 | 13,652,467 | 13.5 M to 13.7 M (+1.24 %) |
| Aug 25 2011 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 14.60 | 4,371 | 63,812 | 13,485,829 | 13.5 M to 13.5 M (+0.03 %) |
| Jul 05 2011 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | J | 0.00 | 10,766 | 0 | 13,481,458 | 13.5 M to 13.5 M (+0.08 %) |